Apollo Hospitals Enterprise Ltd reported its fiscal first quarter earnings with profit at Rs 305.20 crore, posting a growth of 83.2 per cent in comparison to Rs 166.60 crore during the corresponding quarter of FY24, surpassing estimates. It posted revenue from operations at Rs 5085.60 crore, up 15.1 per cent as against Rs 4417.80 crore during the same period of previous financial year. The company EBITDA stood at Rs 675.1 crore.
According to a CNBC TV18 poll, Apollo Hospitals was expected to report Q1 profit at Rs 274 crore and revenue for the quarter in review was estimated at Rs 5077.7 crore.
Dr Prathap C Reddy, Chairman, Apollo Hospitals Group, said, “Apollo Hospitals has consistently strived to enhance the quality of healthcare delivery, as demonstrated by our flagship facility in Chennai receiving its seventh consecutive accreditation from JCI. This achievement highlights our dedication to patient safety, quality care, and effective leadership, aligning with our commitment to world-class healthcare as our core growth driver. We continue to lead the industry in adopting and implementing best-in-class healthcare solutions and technologies to push the boundaries of healthcare for better patient outcomes.”
“In the first quarter of FY25, we have seen significant growth and improved the reach of our retail operations. As we continue our growth journey, we remain dedicated to advancing healthcare excellence, implementing innovative solutions, and improving access to the best healthcare services throughout India and beyond,” he added.
Apollo Hospitals’ Q1 performance across segments
Healthcare Services (Hospitals): Apollo Hospitals had 7,942 operating beds across the network (excluding AHLL & managed beds), as on June 30, 2024. The overall occupancy for hospitals was at 68 per cent as against 62 per cent in the same period in the previous year, aided by a strong increase in patient flows across hospitals with inpatient (IP) volume increasing by 11 per cent and outpatient (OP) new registrations by 13 per cent. Revenue of the healthcare services division increased by 15 per cent to Rs 2637.30 crore in Q1FY25. EBITDA (Post Ind AS 116) was at Rs 621.70 crore in Q1FY25. EBITDA was higher by 15 per cent YoY. In terms of regions, revenues in the Tamil Nadu cluster grew by 12 per cent, IP Volumes grew by 6 per cent. Overall occupancy in the cluster was 1,311 beds (64 per cent occupancy). In AP Telangana region, revenues grew by 15 per cent, IP volumes grew by 6 per cent. Occupancy in the cluster was 783 beds (63 per cent occupancy). In Karnataka region, revenues grew by 17 per cent and IP volumes grew by 15 per cent. Occupancy in the cluster was 569 beds (76 per cent occupancy) as. In Eastern region, revenues grew by 14 per cent and IP volumes grew by 11 per cent. Occupancy in the cluster was 1,377 beds (75 per cent occupancy). In Western region, revenues grew by 19 per cent, IP volumes grew by 24 per cent. Occupancy in the cluster was 472 beds (55 per cent occupancy). In Northern region, revenues grew by 15 per cent, IP volumes grew by 12 per cent. Occupancy in the cluster was 875 beds (72 per cent occupancy).
Apollo Health and Lifestyle Limited: AHLL gross revenue was recorded at Rs 366.10 crore, up 15 per cent YoY. The diagnostics business has an overall network of over 2,300+ centres and is spread across around 300 cities serving 15,000+ customers daily. Diagnostics revenue, meanwhile, stood at Rs 116.40 crore and Spectra at Rs 74.30 crore.
Apollo HealthCo: Apollo HealthCo, entered into a binding agreement to raise equity capital of almost $300m (Rs 2475 crore) from private equity investor Advent International. The offline pharmacy distribution revenue stood at Rs 1836.90 crore in Q1FY25 while revenue from digital platform was at Rs 245.20 crore. Overall Health Co revenues were at Rs 2082.10 crore, up 15 per cent YoY. During the quarter, 44 net new stores were opened, taking the total number to 6,074 stores.
